Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) EPS (Weighted Average and Diluted) (2018 - 2026)

Select Medical Holdings (SEM) has disclosed EPS (Weighted Average and Diluted) for 9 consecutive years, with $0.35 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 20.45% year-over-year to $0.35; the TTM value through Mar 2026 reached $1.06, up 1.92%, while the annual FY2025 figure was $1.16, 30.12% down from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.35 in Q1 2026 for Select Medical Holdings, up from $0.16 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.6 in Q2 2024 and bottomed at -$1.13 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.16, with a median of $0.21 recorded in 2022.
  • Year-over-year, EPS (Weighted Average and Diluted) tumbled 405.41% in 2022 and then soared 1050.0% in 2024.
  • Select Medical Holdings' EPS (Weighted Average and Diluted) stood at -$1.13 in 2022, then surged by 110.62% to $0.12 in 2023, then tumbled by 258.33% to -$0.19 in 2024, then soared by 184.21% to $0.16 in 2025, then soared by 118.75% to $0.35 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.35, $0.16, and $0.23 for Q1 2026, Q4 2025, and Q3 2025 respectively.